News
📈 Stocks
Definium Therapeutics Shares Rally 190% YTD on Positive Phase 2 LSD Trial Data
(54 days ago)
Definium Therapeutics shares climb as synthetic LSD treatment shows superior efficacy in Phase 2 anxiety trials, marking another milestone for the biotech…